JP2016506736A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016506736A5 JP2016506736A5 JP2015556262A JP2015556262A JP2016506736A5 JP 2016506736 A5 JP2016506736 A5 JP 2016506736A5 JP 2015556262 A JP2015556262 A JP 2015556262A JP 2015556262 A JP2015556262 A JP 2015556262A JP 2016506736 A5 JP2016506736 A5 JP 2016506736A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- heregulin
- cells
- chga
- kinase inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/761,078 | 2013-02-06 | ||
| US13/761,078 US9109245B2 (en) | 2009-04-22 | 2013-02-06 | Cell compositions derived from dedifferentiated reprogrammed cells |
| PCT/US2014/015156 WO2014124172A1 (en) | 2013-02-06 | 2014-02-06 | Cell compositions derived from dedifferentiated reprogrammed cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019078983A Division JP6721752B2 (ja) | 2013-02-06 | 2019-04-18 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016506736A JP2016506736A (ja) | 2016-03-07 |
| JP2016506736A5 true JP2016506736A5 (https=) | 2017-03-09 |
| JP6517702B2 JP6517702B2 (ja) | 2019-05-22 |
Family
ID=50239931
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015556262A Active JP6517702B2 (ja) | 2013-02-06 | 2014-02-06 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
| JP2019078983A Active JP6721752B2 (ja) | 2013-02-06 | 2019-04-18 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
| JP2020104982A Active JP7250731B2 (ja) | 2013-02-06 | 2020-06-18 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
| JP2022172222A Active JP7550830B2 (ja) | 2013-02-06 | 2022-10-27 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
| JP2024151116A Pending JP2025000625A (ja) | 2013-02-06 | 2024-09-03 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019078983A Active JP6721752B2 (ja) | 2013-02-06 | 2019-04-18 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
| JP2020104982A Active JP7250731B2 (ja) | 2013-02-06 | 2020-06-18 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
| JP2022172222A Active JP7550830B2 (ja) | 2013-02-06 | 2022-10-27 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
| JP2024151116A Pending JP2025000625A (ja) | 2013-02-06 | 2024-09-03 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2954045A1 (https=) |
| JP (5) | JP6517702B2 (https=) |
| AU (5) | AU2014214879A1 (https=) |
| CA (2) | CA3212301A1 (https=) |
| HK (1) | HK1218139A1 (https=) |
| IL (5) | IL311689B2 (https=) |
| RU (2) | RU2675928C2 (https=) |
| WO (1) | WO2014124172A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9109245B2 (en) | 2009-04-22 | 2015-08-18 | Viacyte, Inc. | Cell compositions derived from dedifferentiated reprogrammed cells |
| AU2015300020B2 (en) | 2014-08-04 | 2021-04-08 | Orizuru Therapeutics, Inc. | Method for proliferation of pancreatic progenitor cells |
| DK3443073T3 (da) * | 2016-04-14 | 2024-09-02 | Janssen Biotech Inc | Differentiering af pluripotente stamceller til intestinale mellemtarmendodermceller |
| CN111334463B (zh) * | 2016-05-18 | 2024-02-20 | 学校法人庆应义塾 | 类器官培养用细胞培养基、培养方法及类器官 |
| EP3587560A4 (en) | 2017-01-27 | 2020-12-16 | Kaneka Corporation | Endodermal cell mass, and method for producing any one of three primary germ layer cell mass from pluripotent cells |
| CN111565707A (zh) | 2017-06-14 | 2020-08-21 | 森玛治疗公司 | 用于递送治疗物的装置和方法 |
| EP3654996A4 (en) * | 2017-07-21 | 2021-03-24 | Semma Therapeutics, Inc. | REAGGREGATION OF PANCREAS BETA CELLS FROM STEM CELLS |
| US20210292708A1 (en) * | 2018-08-03 | 2021-09-23 | Kyoto University | Cell production method |
| BR112021004815A2 (pt) * | 2018-09-19 | 2021-06-01 | Takeda Pharmaceutical Company Limited | células produtoras de insulina, medicamento, e, métodos para produzir células produtoras de insulina, para gerar células do tipo ilhota pancreática, para tratar diabetes mellitus, para melhorar e/ou manter o controle dos níveis de glicose em jejum e pós-prandial em um paciente e para reduzir o risco de hipoglicemia em um paciente com diabetes mellitus |
| WO2020243665A1 (en) | 2019-05-31 | 2020-12-03 | W. L. Gore & Associates, Inc. | A biocompatible membrane composite |
| WO2020243666A1 (en) | 2019-05-31 | 2020-12-03 | W. L. Gore & Associates, Inc. | A biocompatible membrane composite |
| AU2020282355B2 (en) | 2019-05-31 | 2023-11-02 | Viacyte, Inc. | A biocompatible membrane composite |
| CN114401752B (zh) | 2019-05-31 | 2023-04-04 | W.L.戈尔及同仁股份有限公司 | 具有受控氧扩散距离的细胞封装装置 |
| IL300105A (en) | 2020-07-31 | 2023-03-01 | Vertex Pharma | Pancreatic endocrine cell differentiation |
| CN119948151A (zh) * | 2022-09-26 | 2025-05-06 | 国立大学法人京都大学 | 胰腺内胚层细胞的制造方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE397959T1 (de) * | 1999-04-06 | 2008-07-15 | Genentech Inc | Verwendung von erbb-rezeptorliganden zur behandlung von diabetes |
| US6759039B2 (en) * | 2000-06-30 | 2004-07-06 | Amcyte, Inc. | Culturing pancreatic stem cells having a specified, intermediate stage of development |
| CA2435826A1 (en) * | 2001-01-24 | 2002-08-01 | The Government Of The United States Of America | Differentiation of stem cells to pancreatic endocrine cells |
| CN101310012B (zh) * | 2005-10-14 | 2012-05-09 | 明尼苏达大学董事会 | 非胚胎干细胞分化成具有胰腺表型的细胞 |
| AU2007254766A1 (en) * | 2006-06-02 | 2007-12-13 | University Of Georgia Research Foundation, Inc. | Pancreatic and liver endoderm cells and tissue by differentiation of definitive endoderm cells obtained from human embryonic stems |
| AU2009313870B2 (en) | 2008-11-14 | 2013-07-11 | Viacyte, Inc. | Encapsulation of pancreatic cells derived from human pluripotent stem cells |
| US9109245B2 (en) * | 2009-04-22 | 2015-08-18 | Viacyte, Inc. | Cell compositions derived from dedifferentiated reprogrammed cells |
| US20100272695A1 (en) * | 2009-04-22 | 2010-10-28 | Alan Agulnick | Cell compositions derived from dedifferentiated reprogrammed cells |
| US8685726B2 (en) * | 2009-04-27 | 2014-04-01 | Viacyte, Inc. | Small molecules supporting pluripotent cell growth and methods thereof |
| EP2436397B1 (en) * | 2009-05-29 | 2017-05-10 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical composition containing antagonist of egf family ligand as component |
-
2014
- 2014-02-06 CA CA3212301A patent/CA3212301A1/en active Pending
- 2014-02-06 IL IL311689A patent/IL311689B2/en unknown
- 2014-02-06 JP JP2015556262A patent/JP6517702B2/ja active Active
- 2014-02-06 AU AU2014214879A patent/AU2014214879A1/en not_active Abandoned
- 2014-02-06 RU RU2015131279A patent/RU2675928C2/ru active
- 2014-02-06 HK HK16106057.9A patent/HK1218139A1/zh unknown
- 2014-02-06 RU RU2018144412A patent/RU2754089C2/ru active
- 2014-02-06 EP EP14708981.7A patent/EP2954045A1/en active Pending
- 2014-02-06 WO PCT/US2014/015156 patent/WO2014124172A1/en not_active Ceased
- 2014-02-06 IL IL290717A patent/IL290717B2/en unknown
- 2014-02-06 CA CA2898431A patent/CA2898431C/en active Active
- 2014-02-06 IL IL321825A patent/IL321825A/en unknown
-
2015
- 2015-07-15 IL IL239953A patent/IL239953B/en active IP Right Grant
-
2019
- 2019-02-26 AU AU2019201314A patent/AU2019201314B2/en active Active
- 2019-04-18 JP JP2019078983A patent/JP6721752B2/ja active Active
-
2020
- 2020-06-18 JP JP2020104982A patent/JP7250731B2/ja active Active
-
2021
- 2021-05-10 IL IL283088A patent/IL283088B/en unknown
-
2022
- 2022-01-07 AU AU2022200075A patent/AU2022200075C1/en active Active
- 2022-10-27 JP JP2022172222A patent/JP7550830B2/ja active Active
-
2023
- 2023-04-26 AU AU2023202507A patent/AU2023202507B2/en active Active
-
2024
- 2024-09-03 JP JP2024151116A patent/JP2025000625A/ja active Pending
-
2026
- 2026-03-02 AU AU2026201562A patent/AU2026201562A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016506736A5 (https=) | ||
| Kim et al. | Activation of miR-21-regulated pathways in immune aging selects against signatures characteristic of memory T cells | |
| RU2015131279A (ru) | Композиции клеток, полученные из дедифференцированных перепрограммированных клеток | |
| Maudet et al. | Functional high-throughput screening identifies the miR-15 microRNA family as cellular restriction factors for Salmonella infection | |
| ZA202003137B (en) | Nucleic acid, composition and conjugate containing same, and preparation method and use | |
| Sousa et al. | Exit from naive pluripotency induces a transient X chromosome inactivation-like state in males | |
| Comes et al. | L-Proline induces a mesenchymal-like invasive program in embryonic stem cells by remodeling H3K9 and H3K36 methylation | |
| Bagci et al. | DNA demethylation in pluripotency and reprogramming: the role of tet proteins and cell division | |
| Waghray et al. | Tbx3 controls Dppa3 levels and exit from pluripotency toward mesoderm | |
| JP2016513972A5 (https=) | ||
| NZ607608A (en) | Method of producing pancreatic hormone-producing cells | |
| Diallo et al. | A tRNA-derived fragment present in E. coli OMVs regulates host cell gene expression and proliferation | |
| JP2016521971A5 (https=) | ||
| JP2017515507A5 (https=) | ||
| WO2010008486A3 (en) | Pluripotent cell lines and methods of use thereof | |
| MY191740A (en) | Production method for nerve tissue | |
| WO2012021632A3 (en) | Generation and use of pluripotent stem cells | |
| BR112015019950A2 (pt) | Método para gerar linhagem de células-tronco embrionárias (es) de rato, e, cultura in vitro | |
| WO2006127150A3 (en) | Dendritic cell compositions and methods | |
| MY183058A (en) | Production method for retinal tissue | |
| WO2015120096A3 (en) | Methods for producing autologous t cells useful to treat b cell malignancies and other cancers and compositions thereof | |
| CY1122993T1 (el) | Μεθοδος παραγωγης για πολυδυναμα βλαστοκυτταρα που εχουν αντιγονο-ειδικο γονιδιο υποδοχεα τ κυτταρων | |
| EP3204490A1 (en) | Endogenous retrovirus transcription as a marker for primate naïve pluripotent stem cells | |
| WO2015108944A3 (en) | Stem cell-derived hepatocytes in co-culture and uses thereof | |
| EP4495246A3 (en) | Techniques for generating cell-based therapeutics using recombinant t cell receptor genes |